Common diabetes drug may shield leg artery patients from heart attacks and amputations

NCT ID NCT07157475

Recruiting now Knowledge-focused Sponsor: Wroclaw Medical University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times

Summary

This study is checking if a type of diabetes medicine called SGLT-2 inhibitors (or 'flozins') can lower the risk of serious heart problems and limb complications in people who have had surgery to open blocked leg arteries. Researchers will look back at 300 patients who had the surgery at least a year ago and compare those who took the drug to those who did not. The goal is to see if the drug helps prevent heart attacks, strokes, repeat procedures, or amputations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE (PAD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Wroclaw Medical University
RECRUITING

Wroclaw, Lower Silesian Voivodeship, Poland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PERIPHERAL ARTERIAL DISEASE (PAD)